Evidence mapPaperPMID 31893939Full record

ArticleCirculation2020

DP1 Activation Reverses Age-Related Hypertension Via NEDD4L-Mediated T-Bet Degradation in T Cells.

Deping Kong, Qiangyou Wan, Juanjuan Li, Shengkai Zuo, Guizhu Liu, Qian Liu, Chenchen Wang, Peiyuan Bai, Sheng-Zhong Duan, Bin Zhou and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Circulation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Prostanoids in Cardiac and Vascular Remodeling.Arteriosclerosis, thrombosis, and vascular biology · 2024
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. The Effect of Lipid Metabolism on CD4Mediators of inflammation · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 9 institutions in 3 countries.

Deping KongDepartment of Pharmacology and Tianjin Key Laboratory of Inflammatory Biology, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), School of Basic Medical Sciences, Tianjin Medical University, China (D.K., S.Z., Q.L., Y.Y.).
Qiangyou WanCAS Key Laboratory of Nutrition, Metabolism and Food Safety, Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences (Q.W., C.W., Y.Y.), University of Chinese Academy of Sciences, Chinese Academy of Sciences, China.
Juanjuan LiDepartment of Gastroenterology (J.L.), Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China.
Shengkai ZuoDepartment of Pharmacology and Tianjin Key Laboratory of Inflammatory Biology, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), School of Basic Medical Sciences, Tianjin Medical University, China (D.K., S.Z., Q.L., Y.Y.).
Guizhu LiuNational Clinical Research Center for Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, China (G.L., Y.Y.).
Qian LiuDepartment of Pharmacology and Tianjin Key Laboratory of Inflammatory Biology, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), School of Basic Medical Sciences, Tianjin Medical University, China (D.K., S.Z., Q.L., Y.Y.).
Chenchen WangCAS Key Laboratory of Nutrition, Metabolism and Food Safety, Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences (Q.W., C.W., Y.Y.), University of Chinese Academy of Sciences, Chinese Academy of Sciences, China.
Peiyuan BaiDepartment of Cardiology (P.B., A.L.), Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China.
Sheng-Zhong DuanLaboratory of Oral Microbiology, Shanghai Research Institute of Stomatology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, China (S.-Z.D.).
Bin ZhouState Key Laboratory of Cell Biology, Chinese Academy of Sciences Center for Excellence on Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology (B.Z.), University of Chinese Academy of Sciences, Chinese Academy of Sciences, China.
Fotini GounariDivision of Rheumatology and Knapp Center for Lupus and Immunology Research, University of Chicago, IL (F.G.).
Ankang LyuDepartment of Cardiology (P.B., A.L.), Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China.
Michael LazarusInternational Institute for Integrative Sleep Medicine (WPI-IIIS), University of Tsukuba, Tsukuba City, Ibaraki, Japan (M.L.).
Richard M BreyerDepartment of Veterans Affairs, Tennessee Valley Health Authority, and Department of Medicine, Vanderbilt University Medical Center, Nashville, TN (R.M.B.).
Ying YuDepartment of Pharmacology and Tianjin Key Laboratory of Inflammatory Biology, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), School of Basic Medical Sciences, Tianjin Medical University, China (D.K., S.Z., Q.L., Y.Y.).
Ruijin Hospital · CNShanghai Institute of Nutrition and Health · CNTianjin Medical University · CNCenter for Excellence in Molecular Cell Science · CNFirst Affiliated Hospital of Guangzhou Medical University · CNShanghai Ninth People's Hospital · CNTennessee Valley Authority · USTsukuba International University · JPUniversity of Chicago · US

Funding

TARGETED DISRUPTION OF THE 5-LIPOXYGENASE GENE IN MICEP50GM015431 · VANDERBILT UNIVERSITY · 1985 to 2005
$7.4M
Signaling in the DN to DP thymocyte transitionR01AI059676 · TUFTS MEDICAL CENTER · 2004 to 2005
$732k
NIAID NIH HHS R01 AI059676NIAID NIH HHS R01 AI108682NIGMS NIH HHS P50 GM015431
6 · The paper itself

Abstract

backgroundBlood pressure often rises with aging, but exact mechanisms are still not completely understood. With aging, the level of proinflammatory cytokines increases in T lymphocytes. Prostaglandin D

methodsTo clarify the physiological and pathophysiological roles of DP1 in T cells with aging, peripheral blood samples were collected from young and older male participants, and CD4

resultsThe prostaglandin D

conclusionsThe prostaglandin D

Indexed as

AgingAgedAnimalsAntihypertensive AgentsCD4-Positive T-LymphocytesCyclic AMP-Dependent Protein KinasesCytokinesHumansHypertensionMiceMice, Inbred C57BLNedd4 Ubiquitin Protein LigasesProstaglandin D2Receptors, ProstaglandinSignal TransductionSp1 Transcription FactorAntihypertensive AgentsCyclic AMP-Dependent Protein KinasesCytokinesNedd4l protein, mouseNedd4 Ubiquitin Protein LigasesProstaglandin D2Receptors, ProstaglandinSp1 Transcription FactorSuperoxidesT-bet Transcription FactorT-Box Domain ProteinsagingD-prostanoid receptor 1hypertensionlymphocyteprostaglandin (PG) D2

Identifiers

PMID31893939
PMCPMC8232565
OpenAlexW2997919273

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.